Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

431
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
431
Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

289
Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
289

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reference map of multimodal vision deficits in intermediate age-related macular degeneration: contrast sensitivity and low-contrast visual acuity.

The British journal of ophthalmology·2026
Same author

Systemic Statin Use and Reduced Risk of Repeat Retinal Detachment Repair: A Retrospective Cohort Study.

Ophthalmology. Retina·2026
Same author

Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study.

Journal of vitreoretinal diseases·2026
Same author

Cataract Surgery and the Risk of Conversion from Dry to Neovascular Age-related Macular Degeneration in the IRIS© Registry.

Ophthalmology·2026
Same author

Recent vaccination exposure and central serous chorioretinopathy.

Eye (London, England)·2026
Same author

Neuroprotective Agents for Photoreceptor Rescue Following Experimental Retinal Detachment in Rodents: A Systematic Review.

Investigative ophthalmology & visual science·2026

Related Experiment Video

Updated: Mar 9, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.3K

Beyond VEGF-The Weisenfeld Lecture.

Joan W Miller

    Investigative Ophthalmology & Visual Science
    |December 28, 2016
    PubMed
    Summary

    Advances in age-related macular degeneration (AMD) treatment show anti-VEGF therapy is effective but not a cure. Targeting lipid accumulation with statins shows promise for drusen regression and improved vision in AMD patients.

    Area of Science:

    • Ophthalmology
    • Retinal Diseases
    • Macular Degeneration

    Background:

    • Vascular endothelial growth factor (VEGF) inhibitors revolutionized age-related macular degeneration (AMD) treatment, controlling neovascularization.
    • Long-term studies reveal continued degenerative processes and potential atrophic changes with anti-VEGF therapy.
    • Neuroprotection strategies aim to prevent retinal atrophy by blocking apoptotic and necrotic cell death pathways.

    Discussion:

    • Current AMD treatments, including anti-VEGF and neuroprotection, do not address the disease's root cause: abnormal lipid accumulation.
    • Lipid retention in Bruch's membrane and the retinal pigmented epithelium (RPE) is implicated in early AMD and drusen formation.
    • Targeting lipid removal presents a novel therapeutic strategy for AMD.

    Key Insights:

    More Related Videos

    Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development
    09:16

    Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development

    Published on: May 31, 2024

    2.4K
    Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
    09:03

    Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

    Published on: June 30, 2023

    1.8K

    Related Experiment Videos

    Last Updated: Mar 9, 2026

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
    09:04

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

    Published on: March 15, 2016

    10.3K
    Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development
    09:16

    Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development

    Published on: May 31, 2024

    2.4K
    Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
    09:03

    Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

    Published on: June 30, 2023

    1.8K
    • High-dose statin therapy demonstrated significant drusen regression and improved visual acuity in a case study and pilot trial.
    • These preliminary findings suggest statins may be a viable approach to manage lipid accumulation in AMD.
    • Further investigation into statin therapy for AMD is warranted based on these encouraging results.

    Outlook:

    • Future AMD treatments must be biologically driven, requiring deeper understanding of pathogenic mechanisms.
    • Promising therapeutic targets include neuroprotection, immune pathways (inflammation, complement, inflammasomes), and lipid/lipoprotein management.
    • Improved phenotyping and classification are crucial for advancing AMD therapy due to disease heterogeneity.